27 Mid Cap Stocks Hit 52-Week Highs On Thursday
A list of new market highs contains very different kinds of corporate strength.
Everpure (P) has gained 65.9% over the last month, leading a list of 27 Mid Cap stocks hitting new 52-week highs on Thursday. That run stands out in a market where the S&P 500 returned just +3.1% over the same period, raising a central question: what kind of business performance is earning these new market peaks?
The names below show a wide range of answers.
The 10 Largest, By Market Cap
- CoreWeave Is A Diversifier That Does Not Calm The Ride
- A 8-Day Winning Streak Has Kymera Therapeutics Stock Up 14%
- The Tables Have Turned: A Year Ago Hewlett Packard Was The Cheaper Bet, Not Dell and Super Micro
- Veeva Systems Stock Climbs 25% On A 10-Day Winning Streak
- A 5-Day Winning Streak Has Circle Internet Stock Up 19%
- Get Paid 22% A Year To Let Someone Else Chase MU Stock Higher
The table below shows the 10 largest of the 27 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| EXPE | $40.0 Bil | 0.8% | 7.1% | 22.9% | 62.9% |
| P | $38.9 Bil | 5.3% | 34.5% | 65.9% | n/a |
| MDB | $38.0 Bil | 7.9% | 27.6% | 41.8% | 127.3% |
| DXCM | $35.2 Bil | 0.7% | 10.2% | 25.8% | 14.1% |
| CFG | $31.5 Bil | 0.3% | 2.3% | 4.9% | 58.6% |
| HPQ | $28.9 Bil | 6.9% | 11.1% | 31.8% | 23.7% |
| CPAY | $28.7 Bil | 3.8% | 6.8% | 17.1% | 37.5% |
| OKTA | $27.3 Bil | 5.2% | 8.0% | 2.7% | 73.5% |
| SN | $26.7 Bil | 1.3% | 4.8% | 25.7% | 61.5% |
| OMC | $26.3 Bil | 3.3% | 7.1% | 9.2% | 24.7% |
Which of these new highs is earned by the underlying business?
Look at Everpure (P) again. Its powerful one-month run has pushed its valuation to 171.8 times trailing earnings. That multiple is supported by 21.0% revenue growth over the last twelve months, but the company’s operating margin is just 4.2%.
Contrast that with Expedia (EXPE), the largest name on today’s list. It trades at a more conventional 19.4 times trailing earnings, backed by a 17.4% operating margin.
Is a 52-week high a buy signal or a warning?
Neither. A stock at its strongest price of the last year is a sign of market recognition, and strength often persists. But a high is a price, not a verdict on the business itself.
The disciplined approach is to treat this list as a screen for ideas, not a set of recommendations. The essential work comes next: checking whether the company’s growth and profitability can justify the market’s new level of enthusiasm.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.